Approvals in the U.S. and Europe had allowed for the launch of new drugs like the prostate drug Zytiga and the pain drug Nucynta.

FORBES: JNJ Profit Drops, Revenue Jumps As New Drugs Are Rolled Out

Likewise, Misono says that clinicians and researchers may need to pay greater attention to common risk factors for prostate cancer and suicide, such as depression, pain, and decreased quality of life.

CNN: STORY HIGHLIGHTS

Provenge is a first-of-its-kind therapy that extends life for patients with prostate cancer that has spread but is not yet causing pain or other symptoms.

FORBES: Good News For Dendreon As Manufacturing Site Approved

It is more than a year away from getting approval to treat pain from bone cancer lesions and is targeting prostate, breast and brain tumors.

FORBES: Magazine Article

Well, there is a reference to the pain of the test itself, presumably the PSA (Prostate Specific Antigen) test.

FORBES: Head-In-The-Sand Medicine: To Test Or Not To Test

In September of this year, driven by pain he could no longer ignore, he went to his doctor who discovered a rock-hard prostate gland.

FORBES: Can Big Data Save My Dad From Cancer?